Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

Domestic drug companies in India are preparing to launch affordable generics of the diabetes drug Empagliflozin after the ...

A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

The Indian Pharmaceutical Alliance refutes a study claiming Indian generic drugs have higher adverse events, stating quality ...

Introduction of a direct-to-patient delivery model for its weight-loss drug in the United States could potentially delay its ...

Dilip Shanghvi, chairman of India's largest drugmaker Sun Pharma, told an industry gathering last week that his company sells ...

Dehradun: An Indian pharmaceutical firm, whose products Singapore's Health Sciences Authority (HSA) allegedly issued images ...

A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...

The USFDA has established an office in India to oversee the number of Indian manufacturers qualified to supply generic ...

New Delhi, A trends study conducted by the federal financial intelligence unit of India has expressed "suspicion" that ...